Skip to main content
. 2018 Feb 28;14(2):191–199. doi: 10.3988/jcn.2018.14.2.191

Table 1. Patient characteristics at baseline.

Variables Overall (n=2,470) Institutionalized (n=421, 17.0%) Not institutionalized (n=2,049, 83.0%) p
Age (year) 74.5±7.8 75.4±7.7 74.3±7.8 <0.01*
Female 1,683 (68.1) 300 (71.3) 1,383 (67.5) 0.13
Education (year) 6.3±5.1 5.7±4.9 6.4±5.2 <0.01*
Dementia severity and clinical variables
 MMSE score 18.2±5.1 16.2±5.1 18.6±5.0 <0.01*
 CDR-SB score 5.3±3.0 6.6±3.5 5.1±2.9 <0.01*
 NPI score 15.2±18.1 20.4±21.8 14.1±17.1 <0.01*
GDS score 7.1±4.4 6.9±4.4 7.1±4.4 0.53
Comorbidities
 Hypertension 1,245 (50.4) 197 (46.8) 1,048 (51.2) 0.10
 Diabetes mellitus 615 (24.9) 109 (25.9) 506 (24.7) 0.60
 Cardiovascular disease 392 (15.9) 62 (14.7) 330 (16.1) 0.48
 Stroke 200 (8.1) 34 (8.1) 166 (8.1) 0.98
Alcohol consumption 0.05
 Current 1,310 (78.9) 286 (82.7) 1,024 (77.9)
 Never 351 (21.1) 60 (17.3) 291 (22.1)
Smoking 0.79
 Current smoker 134 (8.1) 26 (7.5) 108 (8.2)
 Ex-smoker 336 (20.2) 67 (19.4) 269 (20.5)
 Never smoked 1,191 (71.7) 253 (73.1) 938 (71.3)
Living with main caregiver 1,452 (59.1) 235 (56.0) 1,217 (59.7) 0.15
Main caregiver 0.01*
 Spouse 715 (29.2) 95 (22.6) 620 (30.5)
 Son/daughter-in-law 927 (37.8) 183 (43.6) 744 (36.6)
 Daughter/son-in-law 709 (28.9) 120 (28.6) 589 (29.0)
 Others 100 (4.1) 22 (5.2) 78 (3.8)
Medications
 ChEI/memantine 2,114 (89.9) 370 (87.9) 1,744 (85.1) 0.14
 Antipsychotic 249 (10.1) 66 (15.7) 183 (8.9) <0.01*
 Benzodiazepine 1,554 (62.9) 248 (58.9) 1,306 (63.7) 0.06

Data are mean±standard-deviation or n (%) values.

*p<0.05 between institutionalized and not-institutionalized patients.

CDR-SB: Clinical Dementia Rating Sum of Boxes, ChEI: cholinesterase inhibitors, GDS: Geriatric Depression Scale, MMSE: Mini Mental State Examination, NPI: NeuroPsychiatric Inventory.